Gideon Shapiro
Corporate Officer/Principal at BRIGHT MINDS BIOSCIENCES INC.
Net worth: 362 032 $ as of 31/05/2024
Network origin in Gideon Shapiro first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 12 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Gideon Shapiro via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| QHSLAB, INC. | Financial Conglomerates | Corporate Officer/Principal | |
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| FUSE BATTERY METALS INC. | Other Metals/Minerals | Director/Board Member | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
NeuroNascent, Inc.
 NeuroNascent, Inc. Pharmaceuticals: MajorHealth Technology NeuroNascent, Inc. is an IND-enabling stage biopharmaceutical company that develops orally available, novel therapeutics aimed at halting or reversing chronic neurological disorders. It offers disease-modifying therapeutics for some of the most difficult to treat brain disorders that include Alzheimer's disease, Parkinson's disease, and Down syndrome. The Company is founded by Judith Kelleher-Andersson in May 2004 and is headquartered in Clarksville, MD. | Pharmaceuticals: Major | Director/Board Member | |
| INTENSITY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| FISSION URANIUM CORP. | Other Metals/Minerals | Director of Finance/CFO | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal Masters Business Admin | |
| University of Pittsburgh | College/University | Corporate Officer/Principal | |
| RHÖN-KLINIKUM AG | Hospital/Nursing Management | Corporate Officer/Principal | |
| University of Bath | College/University | Doctorate Degree | |
| The University of Edinburgh | College/University | Doctorate Degree | |
| University of California San Diego | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Illinois | College/University | Corporate Officer/Principal | |
| University of Vermont | College/University | Corporate Officer/Principal | |
| University College Dublin | College/University | Doctorate Degree | |
| Technical University of Denmark | College/University | Graduate Degree | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Alzheimers Drug Discovery Foundation
 Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr. | Biotechnology | Corporate Officer/Principal | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Chairman | |
Psychogenics, Inc.
 Psychogenics, Inc. Pharmaceuticals: MajorHealth Technology Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
The Royal College of Psychiatrists
 The Royal College of Psychiatrists Financial ConglomeratesFinance The Royal College of Psychiatrists is a professional body responsible for education and training, and setting and raising standards in psychiatry. The non-profit company is based in London, UK. The British company provides a guide to suicide-related information and resources on their website, as well as special interest groups for members to come together in a particular area of psychiatry. The company also has a building capacity project funded by Health Education England and focus on quality improvement to improve the quality of care delivered to patients. The information they provide is for any woman who has - or thinks she may have - perinatal OCD, as well as partners, family, and friends who want to find out more. | Financial Conglomerates | Corporate Officer/Principal | |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Founder | |
| AVADEL PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| LIBERTY HEALTH SCIENCES INC. | Agricultural Commodities/Milling | Director of Finance/CFO | |
| Georgetown University Medical Center | College/University | Corporate Officer/Principal | |
Friday's Dog, Inc.
 Friday's Dog, Inc. Household/Personal CareConsumer Non-Durables Friday's Dog, Inc. is a premium consumer packaged goods (CPG) Canadian company specializing in dog-care products. The private company is based in Vancouver, Canada. The company primarily sells their products through direct-to-consumer (DTC) channels. The company's product range includes treats, shampoos, conditioners, grooming and care products, and dog lifestyle accessories. The company has launched with nine ready-made products for ecommerce and are constantly developing new items to match market trends. Friday's Dog is supported by experienced financers and independent directors who advise on the company's expected growth. The company was founded in 2022 and is guided by a strong marketing team. The company was founded in 2019 by David Babaii, and Jeremy T. Ross has been the CEO since 2022. | Household/Personal Care | Director of Finance/CFO | |
Sunvest Minerals Corp.
 Sunvest Minerals Corp. Precious MetalsNon-Energy Minerals Sunvest Minerals Corp. engages in gold exploration. The private company is based in Vancouver, Canada. | Precious Metals | Director of Finance/CFO | |
| ALMA GOLD INC. | Precious Metals | Director of Finance/CFO | |
| MONUMENTAL ENERGY CORP. | Precious Metals | Director of Finance/CFO | |
| REX RESOURCES CORP. | Other Metals/Minerals | Director of Finance/CFO | |
| PASITHEA THERAPEUTICS CORP. | Pharmaceuticals: Major | Director/Board Member | |
| Starwise Therapeutics LLC | Chief Executive Officer | ||
| SAMURAI CAPITAL CORP. | Financial Conglomerates | Director of Finance/CFO | |
| RHÖN-Innovations GmbH | Corporate Officer/Principal | ||
| Pgi Drug Discovery LLC | Chief Executive Officer | ||
| LONGHORN EXPLORATION CORP. | Other Metals/Minerals | Director of Finance/CFO | |
| US CRITICAL METALS CORP. | Financial Conglomerates | Director of Finance/CFO | |
Copper King Resources Corp.
 Copper King Resources Corp. Other Metals/MineralsNon-Energy Minerals Copper King Resources Corp. operates as a mineral exploration company. It is engaged in the identification, acquisition and exploration of mineral properties. The firm’s main emphasis is the exploration of the McNulty Property located in the Clinton Mining Division, British Columbia. The company was founded on January 13, 2021 and is headquartered in Vancouver, Canada. | Other Metals/Minerals | Director of Finance/CFO | |
| FRIDAY'S DOG HOLDINGS INC. | Financial Conglomerates | Director of Finance/CFO | |
| VOLTAGE METALS CORP. | Other Metals/Minerals | Director of Finance/CFO | |
| UB School of Medicine & Biomedical Sciences | College/University | Doctorate Degree |
Statistics
International
| United States | 27 |
| Canada | 16 |
| United Kingdom | 4 |
| Denmark | 3 |
| Germany | 3 |
Sectoral
| Health Technology | 14 |
| Non-Energy Minerals | 12 |
| Consumer Services | 12 |
| Finance | 6 |
| Commercial Services | 4 |
Operational
| Director/Board Member | 50 |
| Director of Finance/CFO | 46 |
| Corporate Officer/Principal | 30 |
| Corporate Secretary | 21 |
| Chief Tech/Sci/R&D Officer | 15 |
Most connected contacts
| Insiders | |
|---|---|
| Ryan Cheung | 60 |
| David Weiner | 14 |
| Emer Leahy | 12 |
| Revati Shreeniwas | 10 |
| Ian McDonald | 8 |
| Thomas Lategan | 8 |
| Douglas Williamson | 8 |
| Mark A. Smith | 6 |
| Alan Kozikowski | 6 |
| Nils Bottler | 5 |
| Jan Pedersen | 4 |
| Jeremy Fryzuk | 3 |
- Stock Market
- Insiders
- Gideon Shapiro
- Company connections
